Autres langues Hualan Group Co., Ltd.

Actions

301027

CNE100004MH7

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 15/05/2024			Varia. 5j.	Varia. 1 janv.
8,22 ^CNY	+1,36%		-2,61%	-34,29%

07:03	Les centres de collecte de sang de Hualan Biological Engineering obtiennent une licence d'exploitation	MT
23/04	Hualan Group Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hualan Biological Engineering's Blood Centers Get License to Operate	07:03
Hualan Group Co., Ltd. Proposes Final Dividend for 2023	24/04
Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates	02/04
Hualan Biological Engineering Obtains Blood Collection License	02/02
Hualan Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23
Hualan Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood	16/08/23
Hualan Group Unit Secures Construction Enterprise Qualification Certificate	04/08/23
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection	07/07/23
Hualan Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023	14/06/23
Hualan Biological Engineering Obtains Blood Plasma Collection License	31/05/23
Hualan Group Co., Ltd. Approves Cash Dividend for the Year 2022	17/05/23
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug	05/05/23
Hualan Group Co., Ltd. Proposes Cash Final Dividend for 2022	25/04/23
Hualan Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/04/23
Hualan Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/04/23
Hualan Biological Bacterin to Return to Profit in Q1	10/04/23
Hualan Biological Bacterin Gets Certification for Tetanus Vaccine	28/02/23
Hualan Biological Bacterin Registers Freeze-Dried Human Rabies Vaccine	01/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hualan Group Co., Ltd.

Actions

301027

CNE100004MH7

Autres langues

Filtres